ING Group’s NEOPHOTONICS CORP NPTN Stock Holding History

ING Group’s Portfolio NPTN Stock Details NPTN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-382,970	Closed	-$3.35M	–	777
2013 Q2	$3.35M	Buy	+382,970	New	+$2.46M	0.02%	418

Other funds holding NPTN

Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Austin W. Marxe & David M. Greenhouse New York $733M AUM 21.72% 1-Year Est. Return

Chilton Investment Company Stamford, Connecticut $4.26B AUM 1.32% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

Argent Capital Management St Louis, Missouri $3.17B AUM 36.16% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

ING Group's NPTN Position: Q3 2013 in Review

ING Group sold out of NEOPHOTONICS CORP (NPTN) in Q3 2013, closing a stake of 382,970 shares — an estimated $3.35M sold.

ING Group first reported a position in NPTN in Q2 2013 and held it in 1 quarter. The position peaked at $3.35M in Q2 2013. 72 funds tracked by Wall St. Rank hold NPTN as of Q3 2013.

ING Group reported no remaining NEOPHOTONICS CORP position as of Q3 2013 after selling out during the quarter.
ING Group sold 382,970 NEOPHOTONICS CORP shares in Q3 2013, an estimated $3.35M.
ING Group first reported a position in NEOPHOTONICS CORP in Q2 2013 and held it in 1 quarter.
ING Group's NEOPHOTONICS CORP position peaked at $3.35M in Q2 2013.
72 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q3 2013.

Based on ING Group's 13F filing for Q3 2013, filed 13 Nov 2013.